Mylan shareholders re-elect board, vote against executive pay

AMSTERDAM (Reuters) - Mylan NV shareholders re-elected the generic drugmaker's board at its annual meeting on Thursday, despite a shareholder campaign to vote down most of the directors in the wake of a scandal related to its high prices for emergency allergy treatment EpiPen.

Mylan shareholders re-elect board, vote against executive pay
Read More


Bagikan Berita Ini